CHAMPIONS ONCOLOGY, INC. (CSBR) Total liabilities 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) total liabilities at each fiscal year-end, per SEC filings.
$22.9MFY2026 · since FY2018: $8.1M → $22.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $22.9M | -19.8% |
| FY2025 | $28.6M | +1.9% |
| FY2024 | $28.0M | -5.5% |
| FY2023 | $29.7M | +12.9% |
| FY2022 | $26.3M | +30.3% |
| FY2021 | $20.2M | +28.8% |
| FY2020 | $15.7M | +73.4% |
| FY2019 | $9.0M | +11.8% |
| FY2018 | $8.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating marginCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Shareholders’ equityCSBR overview →